Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
about
Recombinant human interleukin 10 for induction of remission in Crohn's diseaseFlavonoids in Inflammatory Bowel Disease: A ReviewIdentification of the transcriptional response of human intestinal mucosa to Lactobacillus plantarum WCFS1 in vivo.Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel diseaseNutriose, a prebiotic low-digestible carbohydrate, stimulates gut mucosal immunity and prevents TNBS-induced colitis in piglets.No association of the cytotoxic T-lymphocyte associated gene CTLA4 +49A/G polymorphisms with Crohn's disease and ulcerative colitis in Hungarian population samples.Parent and self-report of sleep-problems and daytime tiredness among adolescents with inflammatory bowel disease and their population-based controls.The role of bacteria in the pathogenesis of inflammatory bowel diseaseDietary intervention with narrow-leaved cattail rhizome flour (Typha angustifolia L.) prevents intestinal inflammation in the trinitrobenzenesulphonic acid model of rat colitisChildhood obesity: a role for gut microbiota?Probiotic Properties of Leuconostoc mesenteroides Isolated from Aguamiel of Agave salmiana.Probiotics and periodontal health.New molecular insights into inflammatory bowel disease-induced diarrhea.Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner.The role of probiotic bacteria in managing periodontal disease: a systematic review.Cellular and molecular effects of yeast probiotics on cancer.Lactobacillus acidophilus attenuates Salmonella-induced intestinal inflammation via TGF-β signaling.Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.Prebiotics in chronic intestinal inflammation.Host-bacteria interaction in inflammatory bowel disease.Probiotics and their derivatives as treatments for inflammatory bowel disease.Care of inflammatory bowel disease patients in remission.Perceptions of medical sciences students towards probioticsSalvia miltiorrhiza (dan shen) significantly ameliorates colon inflammation in dextran sulfate sodium induced colitis.Panax notoginseng attenuates experimental colitis in the azoxymethane/dextran sulfate sodium mouse modelEnhanced Probiotic Potential of Lactobacillus reuteri When Delivered as a Biofilm on Dextranomer Microspheres That Contain Beneficial Cargo.Integrative medicine in allergy and immunology.Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease.The new prophylactic strategy for colon cancer in inflammatory bowel disease by modulating microbiota.Why interleukin-10 supplementation does not work in Crohn's disease patients.A comparative evaluation of the efficacy of probiotic and chlorhexidine mouthrinses on clinical inflammatory parameters of gingivitis: A randomized controlled clinical study.Bioactivity characterization of Lactobacillus strains isolated from dairy products.Sleep and emotional and behavioral symptoms in adolescents with inflammatory bowel disease.The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis.Effects of Probiotics, Prebiotics, and Synbiotics on Human Health.Prospects for the development of probiotics and prebiotics for oral applications.Effects of proanthocyanidins from grape seed on treatment of recurrent ulcerative colitis in rats.Effects of a Lactobacillus reuteri BR11 mutant deficient in the cystine-transport system in a rat model of inflammatory bowel disease.Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats.Kuwanon G Preserves LPS-Induced Disruption of Gut Epithelial Barrier In Vitro.
P2860
Q24236636-9A765E31-E96A-4725-BC92-9FCA596BDBA5Q26748883-0B75625B-7D20-44F2-8E90-973C2DC0C0EFQ33357913-A176962B-CADE-4258-BDAB-634BE6C49AAAQ33515830-16285156-1ECA-46E1-A841-B90B48BE66FEQ34020518-0A0B7BD1-3C53-4A40-8DBB-33B58FA82E83Q34098903-AA0E947B-C6D2-4377-94D3-6FD1BB5F0FF5Q34197632-01D5F4B9-79C2-4148-8B74-520A94CA873CQ34206639-B4CB47C0-12A8-4D98-BC17-F16C7C236C5CQ34257931-A0DCAA34-F2A3-47EB-B93C-4D9632AD9C9AQ35015022-E1F5A6A6-D7FF-4FD5-8D50-9F2322A4B174Q35563037-BD8B420D-49C9-4727-A816-56E89E1603C5Q35581711-B305F1AD-5B98-44EE-8C14-532AAF9D7084Q35582973-7069C006-CCFA-404D-913D-FD66E404922EQ35719834-E763A0E9-2E60-43B4-B8D4-F26A98637F7EQ36029318-D08EF5FB-7185-470E-979C-AFC36AB05110Q36113199-17571F30-A792-4795-8A25-E1D97D3D6D7AQ36131553-99249A78-863C-426F-A450-46FAE6DE6EE4Q37082773-BEA596AA-688F-4F1D-9E69-62C1ECB20E8AQ37285115-B58F937B-AB39-4193-815D-A567B18DBA3AQ37302559-451354FA-67D2-4DBC-BCB9-3303660DFE2AQ37448522-40F8C0CA-DA9F-4467-814F-75B418C0027AQ37540172-858F8D31-0122-4061-ADD2-0A5CB96202A4Q37658978-4053F2F0-8764-42D9-AB7B-0ED9B6291995Q37676247-F3CA3B38-A7C8-496B-9164-EC54676E8600Q37714511-8D63B4AF-7E36-43BA-A9A8-86FC5CEDE851Q37721203-9F7B4AC7-9F47-41C9-9138-20BCA8D63F5CQ38016377-A9DED0C7-0E7E-4177-817D-6DBFC77515E5Q38049367-8C99F7CB-F4C0-4DB5-B9F0-04E537EE4A27Q38068230-7CF97232-3CFB-4282-B3A5-7132D4E62051Q38120519-6328DFD5-DD3F-41F4-B1BC-1762E337959EQ38439977-28000E4E-1ECE-4EA6-9658-C5EA1E487F21Q38848522-9146C092-31D4-49EC-8760-2850AC86461DQ39765408-BD5BE0A7-76D1-4719-861A-6F09A7FDED42Q39961587-7C519BD5-5ACA-4B3A-8A3D-7ECA4CA45715Q40044003-D817F5CB-C310-4F9F-B9DA-BB21CE17E13FQ41972337-E18049CF-276B-4D74-8B59-ECD531614A1BQ42870058-D0CE5E99-DFC6-4DFD-B689-4079E03F3CA1Q44023499-70BAB966-6394-4FEC-8CB3-7E7C3CB2B4E9Q46249623-301488E4-4EF6-4D3B-9BC0-E16A92B14313Q46455473-7D8BC1E5-55A7-4F0E-B6B3-F868F0DC5455
P2860
Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inflammatory bowel disease: cu ...... cs, prebiotics and synbiotics.
@ast
Inflammatory bowel disease: cu ...... cs, prebiotics and synbiotics.
@en
type
label
Inflammatory bowel disease: cu ...... cs, prebiotics and synbiotics.
@ast
Inflammatory bowel disease: cu ...... cs, prebiotics and synbiotics.
@en
prefLabel
Inflammatory bowel disease: cu ...... cs, prebiotics and synbiotics.
@ast
Inflammatory bowel disease: cu ...... cs, prebiotics and synbiotics.
@en
P1476
Inflammatory bowel disease: cu ...... ics, prebiotics and synbiotics
@en
P2093
Gordon S Howarth
Ross N Butler
P356
10.1016/J.IJFOODMICRO.2006.10.006
P577
2006-11-28T00:00:00Z